Archive for the ‘research’ Category

Risk Factors For Tick Exposure

*Risk factors for tick exposure in suburban settings in the Northeastern
United States*
P. Mead,S. Hook, S. Niesobecki, J. Ray, J. Meek, M. Delorey, C. Prue, A.
Hinckley
Ticks and Tick-borne Diseases, online first 21 November 2017.

https://doi.org/10.1016/j.ttbdis.2017.11.006

Abstract

Prevention of tick-borne diseases requires an understanding of when and
where exposure to ticks is most likely. We used an epidemiologic
approach to define these parameters for residents of a Lyme-endemic region.

Two persons in each of 500 Connecticut households were asked to complete
a log each night for one week during June, 2013. Participants recorded
their whereabouts in 15 min increments (indoors, outdoors in their yard,
outdoors on others’ private property, or outdoors in public spaces) and
noted each day whether they found a tick on themselves. Demographic and
household information was also collected. Logs were completed for 934
participants in 471 households yielding 51,895 time-place observations.

Median participant age was 49 years (range 2–91 years); 52% were female.
Ninety-one participants (9.8%) reported finding a tick during the week,
with slightly higher rates among females and minors. Household factors
positively associated with finding a tick included having indoor/outdoor
pets (odds ratio (OR) = 1.7; 95% confidence interval (CI): 1.1–2.9), the
presence of a bird feeder in the yard (OR = 1.9; CI:1.2–3.2), and
presence of an outdoor dining area (OR = 2.2; CI:1.1–4.3).

Individual factors associated with finding a tick on a given day were
bathing or showering (OR = 3.7; CI:1.3–10.3) and hours spent in one’s
own yard (OR = 1.2, CI:1.1–1.3). Nineteen participants found ticks on
multiple days, more than expected assuming independence (p < 0.001).
Participants who found ticks on multiple days did not spend more time
outdoors but were significantly more likely to be male than those
finding ticks on a single day (p < 0.03).

Our findings suggest that most tick exposures in the study area occurred
on private property controlled by the respective homeowner.
Interventions that target private yards are a logical focus for
prevention efforts.

_______________

For more:  https://madisonarealymesupportgroup.com/2017/07/01/one-tick-bite-could-put-you-at-risk-for-at-least-6-different-diseases/

https://madisonarealymesupportgroup.com/2017/05/01/co-infection-of-ticks-the-rule-rather-than-the-exception/

https://madisonarealymesupportgroup.com/2017/08/17/of-birds-and-ticks/

https://madisonarealymesupportgroup.com/2017/07/30/ticks-found-on-eyeball-buttocks-and-penis/

https://madisonarealymesupportgroup.com/2017/03/13/ticks-found-on-rocks/

https://madisonarealymesupportgroup.com/2017/10/27/israeli-kids-get-lyme-disease-from-ticks-in-caves/

 

Joint Swelling & Inflammation Found in Bb Infected Mice After Treatment with Ceftriaxone

Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice

Siitonen R, Pietikäinen A, Liljenbäck H, Käkelä M, Söderström M, Jalkanen S, Hytönen J, Roivainen A.
Arthritis Research & Therapy, online first Nov 22, 2017.

https://doi.org/10.1186/s13075-017-1460-4

Abstract

Background
In the present study, we sought to evaluate the feasibility of targeting vascular adhesion protein-1 (VAP-1) by positron emission tomography (PET) for the longitudinal quantitative assessment of Borrelia burgdorferi infection-induced inflammation in mice.

Methods
Mice with B. burgdorferi infection-induced arthritis were studied. During a 7-week follow-up period, the progression of arthritis was monitored weekly with 68Ga-DOTA-Siglec-9 PET/computed tomography (CT) and measurement of tibiotarsal joint swellings. A subgroup of infected mice was treated with ceftriaxone. Finally, histopathological assessment of joint inflammation was performed and VAP-1 expression in joints were determined.

Results
Explicit joint swelling and 68Ga-DOTA-Siglec-9 uptake could be demonstrated in the affected joints from B. burgdorferi-infected mice. By contrast, no obvious accumulation of 68Ga-DOTA-Siglec-9 was detected in joints of uninfected mice. The maximum swelling and highest uptake in the affected joints were observed 4 weeks after the infection. 68Ga-DOTA-Siglec-9 uptake in joints correlated with joint swelling (P < 0.0001) and histopathological scoring of inflammation (P = 0.020). Despite short-term antibiotic treatment, the arthritis persisted, and the PET signal remained as high as in nontreated mice. Immunohistochemistry revealed strong-to-moderate expression of VAP-1 in the synovium of B. burgdorferi-infected mice, while only weak expression of VAP-1 was detected in uninfected mice.

Conclusions
The present study showed that 68Ga-DOTA-Siglec-9 can detect B. burgdorferi infection-induced arthritis in mice. Furthermore, longitudinal PET/CT imaging allowed monitoring of arthritis development over time.

Free, full text:
https://doi.org/10.1186/s13075-017-1460-4

______________

For more:  https://madisonarealymesupportgroup.com/2015/09/19/proof-of-borrelia-persistence/

https://madisonarealymesupportgroup.com/2017/08/18/drexel-prof-lyme-persists/

https://madisonarealymesupportgroup.com/2016/12/21/dr-zhang-on-persisters/

https://madisonarealymesupportgroup.com/2017/11/03/lyme-bug-stronger-than-antibiotics-in-animals-and-test-tubes-now-study-people/

Blood Screening for Babesiosis Using Enzymatic Assays

Screening of patient blood samples for babesiosis using enzymatic assays

Primus S, Akoolo L, Schlachter S, Parveen N.
Ticks and Tick-borne Diseases, online first 2017 Nov 12.

https://doi.org/10.1016/j.ttbdis.2017.11.003

Abstract

Human babesiosis is an emerging tick-borne disease in the United States and Europe. Transmitted by Ixodes ticks, the causative agent Babesia microti is an intraerythrocytic parasite that causes mild to deadly disease. Transmission of B. microti can also occur by transfusion of infected blood and blood products resulting in transfusion-transmitted babesiosis (TTB), which carries a high risk of fatality.

To effectively manage this rise in B. microti infections, better screening tools are needed, which require minimal manipulation of the samples before testing. To this end, we tested two enzymatic assays, aspartate aminotransferase (AST) and alanine aminotransferase (ALT), for efficacy in diagnosis of babesiosis. The results show that AST and ALT activity is significantly higher in the plasma of B. microti-infected patients.

Moreover, statistical analysis revealed that these assays have high sensitivity and positive predictive values, which highlights their usefulness as diagnostics for babesiosis. These standardized enzymatic assays can be used to perform high-throughput, large-scale screens of blood and blood products before they are certified safe for transfusion.

____________

For more on Babesia:  https://madisonarealymesupportgroup.com/2016/01/16/babesia-treatment/

https://madisonarealymesupportgroup.com/2016/12/15/blood-screening-for-babesia/

https://madisonarealymesupportgroup.com/2017/07/09/2600-increase-in-babesia-in-12-years-in-wisconsin/

https://madisonarealymesupportgroup.com/2016/11/19/seroprevalence-of-babesia-in-individuals-with-ld/

 

How Multinational Corporations Completely Own Current Day Research

 Approx 2 Min.

Dr. Peter Rost is a former vice president of Pfizer and a whistleblower of the pharmaceutical industry. Author of “The Whistleblower, Confessions of a Healthcare Hitman,” Rost is an insider expert on big pharma marketing.

https://www.healthnutnews.com/pfizer-vice-president-blows-whistle-on-gardasil-the-vaccine-is-deadly/

This interview is just one part of the One More Girl project, created by two brothers who witnessed their sister’s health decline after getting the HPV vaccine, and ultimately is about Gardasil vaccine deaths (current count is 89 deaths so far).  http://vaccineimpact.com/2011/one-more-girl-documentary-on-gardasil-vaccine-deaths/

Starting with a Kickstarter campaign and filming for three months, with a trailer and an update on release date, their website, Facebook account, and YouTube channel are no longer active.

They seemingly vanished.

Please know all sorts of underhanded things are going on regarding the push for vaccines:  https://madisonarealymesupportgroup.com/2017/11/02/astroturfing-wikipedia-contradicts-medical-research-90-of-the-time-my-experience-on-linkedin/  A must read article about how big corporations own research, and the fact medical professionals have been caught trolling the internet and bullying anyone who disagrees with their stance.  This has happened to me personally.

“It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of the New England Journal of Medicine.” – Dr. Marcia Angell, a physician and longtime editor-in-chief of the New England Medical Journal (NEMJ) “

“The case against science is straightforward: much of the scientific literature, perhaps half, may simply be untrue. Afflicted by studies with small sample sizes, tiny effects, invalid exploratory analyses, and flagrant conflicts of interest, together with an obsession for pursuing fashionable trends of dubious importance, science has taken a turn towards darkness.” – Dr. Richard Horton, the current editor-in-chief of the Lancet – considered to be one of the most well respected peer-reviewed medical journals in the world. 

This is a frightening state of affairs and patients are the ones who suffer.

For more:

https://madisonarealymesupportgroup.com/2017/01/02/fake-science/

https://madisonarealymesupportgroup.com/2017/01/28/sit-down-science/

https://madisonarealymesupportgroup.com/2017/09/27/strange-case-of-poul-thorsen-vaccine-data-manipulator-extraordinaire/

https://madisonarealymesupportgroup.com/2016/11/29/spider-attacks-cdc/

 

 

 

H.R. 4333 – Lyme Disease Research Stamp Act

For Immediate Release Contact: John Lange
Thursday, November 9, 2017 202-225-5614 | John.Lange@mail.house.gov

Faso Introduces Bipartisan Legislation to Raise Awareness and Research Funding to Combat Lyme Disease

Washington, D.C. – Congressman John Faso (R-Kinderhook) today announced the introduction of H.R. 4333, the bipartisan “Lyme Disease Research Stamp Act” alongside Congressman Collin Peterson (D-MN). The legislation would establish a United States Postal Service semipostal stamp to raise money for Lyme disease and related tick-borne illness research – at no cost to taxpayers.

Congressman Faso said, “Lyme Disease is a scourge that Upstate families know all too well. This debilitating disease stays with its victims for years, and results in immense emotional and financial hardship. Lyme disease and related tick-borne illnesses are growing rapidly, and it is critically important that as a society we do what we can to educate the public on this epidemic so our communities and families can take the necessary steps to comprehensively address this issue.” Faso continued, “The Lyme Disease Research Stamp Act is important because it will help raise awareness and money to support comprehensive research efforts to combat and prevent these devastating diseases.”

Congressman Collin Peterson (MN-7) added, “I am proud to help lead the effort to support increasing funding for Lyme disease and tick-borne illness research and raise public awareness,” Peterson said.

The Lyme Disease Research Stamp Act would establish a United States Postal Service semipostal stamp to raise money for Lyme disease and related tick-borne illness research. The stamp would operate as USPS first-class postage, which postal patrons may voluntarily purchase at a price slightly higher than regular postage to support this cause. Revenue raised would directly benefit critical Lyme disease and related tick-borne illness research at the National Institute of Allergy and Infectious Diseases (NIAID). This market-driven initiative comes at no cost to the taxpayers.

Other leaders in the fight against Lyme Disease contributed their thoughts on the Faso legislation:

“Lyme disease is the number one spreading vector borne epidemic in the U.S, and mimics other chronic diseases accounting for an increased burden of those suffering with chronic illness. It has now been reported in all 50 states, affecting more than 330,000 people a year with debilitating symptoms. Lack of accurate diagnostic testing oftentimes results in diagnoses of Chronic Fatigue Syndrome, Fibromyalgia, autoimmune diseases, unexplained pain syndromes, as well as dementia with neuropsychiatric illness. These various manifestations contribute to disability and rising health care costs. We desperately need to improve diagnostic and treatment options for Lyme and associated illnesses, as research funding to date has been inadequate, so the “Lyme Disease Research Stamp Act” is an excellent way to help raise awareness and provide critical funding for this emerging epidemic”

Dr. Richard Horowitz
NY Times Best-selling author of “Why Can’t I Get Better? Solving the Mystery of Lyme and Chronic Disease” and national best-selling author of “How Can I Get Better? An Action Plan for Treating Resistant Lyme and Chronic Disease”
“The Lyme Disease Research Stamp Act introduced by Congressman Faso enables Congress to provide an opportunity to raise much needed funds for Lyme and other tick-borne diseases research, yet it does not add to the financial burden of the federal government. It enables individuals who want to support Lyme research–so that patients can get proper diagnosis and treatment–to do so without a strain on their budgets and without an unnecessary expenditure of time. Buy a Lyme stamp, help save a life! It’s a win-win situation.”

Pat Smith
President, Lyme Disease Association, Inc.

“Great thanks to Congressman Faso for finding this unique manner to assist with NIH Funding for Lyme disease research. There’s about 80 times as much tick-borne disease as mosquito-borne disease in the USA. Yet funding for Lyme and tick-borne diseases is not commensurate with the illnesses. This legislation will help NIH to address the ticks and the diseases they transmit as is done with mosquitoes.”

Jill Auerbach
Hudson Valley Lyme Disease Association, Chairperson

“We are gratified that Congressman Faso has sought to arrange for a direct way of funding future research for tick borne disease. This epidemic has taken a back seat to mosquito diseases and this legislation will provide a necessary amount of awareness as well as some additional funding. We are grateful to Congressman Faso for his efforts in this area.”

Ira Auerbach
Hudson Valley Lyme Disease Association

“Despite the severity of the epidemic and a rapid growth in reported cases, NIH funding for Lyme disease research has remained relatively low, averaging just $25 million annually. Additional funding is desperately needed for research to develop accurate tests that work in all stages of the disease and for clinical trials to develop more effective treatments for patients with chronic Lyme disease. The Lyme Disease Research Stamp provides an opportunity to help fill this gap at no expense to taxpayers.”

Bruce Fries
President, Patient Centered Care Advocacy Group

Some of Congressman Faso’s efforts to combat Lyme disease in the 115th Congress:

Sent a bipartisan letter to Acting Secretary of the Department of Health and Human Services, Eric Hargan, to follow up on report language for Fiscal Year 2018 appropriations regarding Lyme disease, to improve the measurement and tracking of the progress of federal efforts to combat the disease.
Member of the House Lyme Disease Caucus.
Voted for millions in Lyme and vector-borne disease research funding, in addition to voting for a $2 billion increase in funding to the National Institutes of Health, which conducts important Lyme research.
Sent a letter to U.S. Department of Health and Human Services Secretary Tom Price urging support for the Tick-borne Disease Working Group established under the 21stCentury Cures Act.
Met with leading medical professionals and Lyme disease prevention advocates to share information about ongoing Lyme research and education programs, as well as how private companies are working to develop vaccines.
Facts about Lyme Disease:

An estimated more than 300,000 new cases of Lyme occur annually.
It is found in half of all U.S. counties and on four continents, and it is growing rapidly.
It is transmitted by tick bites.
Symptoms may begin as flu-like but can affect the nervous system, leading to paralysis, encephalitis, seizures, and death if left untreated.
It has no known cure and is difficult to diagnose.
More than 3,000 confirmed cases in NY in 2015.
14 States, including New York, account for over 96% of reported cases.
To view the Letter to Acting Secretary of the Department of Health and Human Services, Eric Hargan, click here.
To learn more about this legislation, click here: https://faso.house.gov/uploadedfiles/lyme_disease_research_stamp_page.pdf
For the full text of the legislation, click here:  https://faso.house.gov/uploadedfiles/draft_-_lyme_disease_research_stamp.pdf

_______________

**Comment**

Sigh……why do Lyme/MSIDS patients, their doctors, and researchers have to sell lemonade to raise money for a disease that’s affecting at least 300,000 per annum and thousands more who are chronically debilitated till they die?  https://www.cdc.gov/lyme/stats/humancases.html

Think about this for a minute.

Can you imagine breast cancer or heart disease patients needing to buy expensive stamps so they can have money for research?

I mean, don’t get me wrong, I appreciate the out of the box thinking by Representative Faso; however, patients are already paying exorbitant amounts of money for treatment that insurance will not even cover.  Then there’s the patients who have become homeless, those who forego treatment, and families who have to choose who gets treated in their family as they can’t afford to treat everyone.  I could go on and on.

According to the CDC, here’s the stats for the leading causes of death in the U.S. with corresponding links showing how LD can cause or exacerbate each of these conditions:

And while I couldn’t find a direct article link to Lyme/MSIDS and “accidents,” Lyme/MSIDS patients trip, fall, and have all sorts of accidents due to neuropathy and brain processing issues, it’s just nobody’s keeping score:  http://www.mentalhealthandillness.com/tnaold.html

According to the CDC, EVERYONE is at risk for Lyme and more folks are diagnosed with Lyme disease (329,000) each year than breast cancer (232,570), colon cancer (136,830), HIV (50,000), and Hepatitis C (18,000).

Take a peek at dollars spent on research:

HIV  $3,005

Breast Cancer  $674

Colon Cancer  $288

Hepatitis  $200

Lyme Disease  $21

*Dollars in millions and rounded. Estimated funding in 2014 by National Institutes of Health (NIH).  https://globallymealliance.org/about-lyme/, Fed funding:  https://report.nih.gov/categorical_spending.aspx

Lyme Disease occurs 6 times more often annually than HIV/AIDS, yet it receives less than 1% of the funding from the National Institutes of Health compared to HIV/AIDS. Likewise, there are 141 times as many cases of Lyme Disease than West Nile virus, yet Lyme Disease receives less than half of the funding for research. http://lymediseasechallenge.org/learn-lyme-disease/

Then there’s the 1.1 billion approved for Zika.

347 symptomatic Zika virus disease cases reported, but 342 cases were in travelers returning from affected areas
2 cases acquired through presumed local mosquito-borne transmission in Florida (N=1) and Texas (N=1)
3 cases acquired through sexual transmission  https://www.cdc.gov/zika/reporting/2017-case-counts.html

Mosquito experts have gone on record stating that mosquito transmission cycles for Zika in the U.S. is near ZERO.  https://madisonarealymesupportgroup.com/2016/07/17/zika-in-the-land-of-oz/, and https://madisonarealymesupportgroup.com/2016/09/04/cdc-report-on-zika/.

But, what about microcephally?

U.N. numbers show just 142 cases of birth defects linked to Zika outside Brazil. The article admits that the condition was initially over diagnosed.  https://madisonarealymesupportgroup.com/2016/10/26/zika-puzzling-scientists/

Call me crazy, but perhaps some reorganization within the CDC/NIH/IDSA needs to happen with proper emphasis on research spending that correlates to incidence of disease…..

Just a silly thought.